quinazolines has been researched along with Aqueductal Stenosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Gao, F; Hua, Y; Keep, RF; Liu, F; Xi, G | 1 |
| Flores, JJ; Klebe, D; Krafft, PR; Lekic, T; McBride, DW; Rolland, WB; Zhang, JH | 1 |
| Kato, Y; Kawamura, H; Makino, T; Nishina, M; Yokoyama, E | 1 |
3 other study(ies) available for quinazolines and Aqueductal Stenosis
| Article | Year |
|---|---|
Hydrocephalus after intraventricular hemorrhage: the role of thrombin.
Topics: Animals; Blood-Brain Barrier; Cerebral Hemorrhage; Cerebral Ventricles; Hydrocephalus; Injections, Intraventricular; Magnetic Resonance Imaging; Male; Pyrroles; Quinazolines; Rats; Rats, Sprague-Dawley; Receptor, PAR-1; Thrombin | 2014 |
Dabigatran ameliorates post-haemorrhagic hydrocephalus development after germinal matrix haemorrhage in neonatal rat pups.
Topics: Administration, Intranasal; Animals; Animals, Newborn; Antithrombins; Dabigatran; Disease Models, Animal; Extracellular Matrix; Hydrocephalus; Injections, Intraperitoneal; Intracranial Hemorrhages; Maze Learning; Oligopeptides; Pyrroles; Quinazolines; Receptor, PAR-1; Rotarod Performance Test | 2017 |
[A case of HER2-positive breast cancer receiving lapatinib+capecitabine chemotherapy with ventriculoperitoneal shunting for hydrocephalus associated with brain metastases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Capecitabine; Deoxycytidine; Fatal Outcome; Female; Fluorouracil; Humans; Hydrocephalus; Lapatinib; Middle Aged; Quinazolines; Receptor, ErbB-2; Ventriculoperitoneal Shunt | 2012 |